BACKGROUND Late gadolinium enhancement (LGE) on cardiac MRI (CMR) has been described as an independent predictive factor of cardiovascular events among patients with hypertrophic cardiomyopathy (HCM). LGE and Q waves are considered as myocardial scar markers but their relation in the context of HCM is poorly established and has to be more supported. The objective of the study was to compare ECG...

Background Ventricular fibrosis in adult congenital heart disease (ACHD) has been shown to relate to adverse clinical markers.[1,2] Novel free-breathing, motion-corrected late gadolinium enhancement cardiovascular magnetic resonance (LGE CMR) has been shown to be advantageous in quantifying LV LGE, but has not been evaluated for RV LGE. [3] It may therefore also be beneficial in ACHD patients, ...

BACKGROUND In idiopathic dilated cardiomyopathy, there are scarce data on the influence of late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance on left ventricular (LV) remodeling. METHODS AND RESULTS Fifty-eight consecutive patients with idiopathic dilated cardiomyopathy underwent baseline clinical, biohumoral, and instrumental workup. Medical therapy was optimized...

BACKGROUND This study investigated the major clinical determinants of late gadolinium enhancement (LGE) at ventricular insertion points (VIPs) commonly seen in patients with pulmonary hypertension (PH). METHODS Forty-six consecutive PH patients (mean pulmonary artery pressure ≥25 mmHg at rest) and 21 matched controls were examined. Right ventricular (RV) morphology, function and LGE mass volu...

The late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is associated with ventricular tachyarrhythmic substrate in patients nonischemic cardiomyopathy (NICM), while the left ejection fraction (LVEF) ≤ 35% still sole criterion for implantable cardioverter defibrillator (ICD) implantation. To perform meta-analysis to evaluate risk stratification value of LVEF and LGE CMR events...

Background Late gadolinium enhancement (LGE) during contrastenhanced cardiac magnetic resonance (CMR) imaging is a powerful predictor of adverse event. However, there are limited data regarding the incidence and prognostic significance of LGE in patients with atrial fibrillation (AF). Furthermore, while CMR is one of the modalities employed in characterizing pulmonary venous anatomy in patients...

BACKGROUND Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) predicts adverse prognosis in patients with stable coronary artery disease (CAD). However, the interaction with conventional risk factors remains uncertain. Our aim was to assess whether the extent of LGE is an independent predictor of adverse cardiac outcome beyond conventional risk factors, including left ven...

AIMS Cardiac involvement is the main determinant of poor outcomes in sarcoidosis. Right ventricular (RV) dysfunction and left ventricular (LV) late gadolinium enhancement (LGE) have been reported to be predictive of adverse outcome in non-ischaemic cardiomyopathies. The aim of our study was to determine whether delayed RV LGE with cardiovascular magnetic resonance would be predictive of adverse...

BACKGROUND Noncontrast magnetic resonance T1 mapping reflects a composite of both intra- and extracellular signal. We hypothesized that noncontrast T1 mapping can characterize the myocardium beyond that achieved by the well-established late gadolinium enhancement (LGE) technique (which detects focal fibrosis) in both hypertrophic (HCM) and dilated (DCM) cardiomyopathy, by detecting both diffuse...

BACKGROUND Myocardial infarction (MI) documented by late gadolinium enhancement (LGE) has clinical and prognostic importance, but its detection is sometimes compromised by poor contrast between blood and MI. MultiContrast Delayed Enhancement (MCODE) is a technique that helps discriminate subendocardial MI from blood pool by simultaneously providing a T2-weighted image with a PSIR (phase sensiti...